Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 98


Serum Amyloid P Component (SAP) Interactome in Human Plasma Containing Physiological Calcium Levels.

Poulsen ET, Pedersen KW, Marzeda AM, Enghild JJ.

Biochemistry. 2017 Feb 14;56(6):896-902. doi: 10.1021/acs.biochem.6b01027. Epub 2017 Feb 1.


Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC).

Kolstoe SE, Jenvey MC, Purvis A, Light ME, Thompson D, Hughes P, Pepys MB, Wood SP.

Acta Crystallogr D Biol Crystallogr. 2014 Aug;70(Pt 8):2232-40. doi: 10.1107/S1399004714013455. Epub 2014 Jul 25.


Distinct Fcγ receptors mediate the effect of serum amyloid p on neutrophil adhesion and fibrocyte differentiation.

Cox N, Pilling D, Gomer RH.

J Immunol. 2014 Aug 15;193(4):1701-8. doi: 10.4049/jimmunol.1400281. Epub 2014 Jul 14.


First identification of resident and circulating fibrocytes in Dupuytren's disease shown to be inhibited by serum amyloid P and Xiapex.

Iqbal SA, Hayton MJ, Watson JS, Szczypa P, Bayat A.

PLoS One. 2014 Jun 16;9(6):e99967. doi: 10.1371/journal.pone.0099967. eCollection 2014.


Coordinated proteomic signature changes in immune response and complement proteins in acute myocardial infarction: the implication of serum amyloid P-component.

Cubedo J, Padró T, Badimon L.

Int J Cardiol. 2013 Oct 15;168(6):5196-204. doi: 10.1016/j.ijcard.2013.07.181. Epub 2013 Jul 30.


Human SAP is a novel peptidoglycan recognition protein that induces complement-independent phagocytosis of Staphylococcus aureus.

An JH, Kurokawa K, Jung DJ, Kim MJ, Kim CH, Fujimoto Y, Fukase K, Coggeshall KM, Lee BL.

J Immunol. 2013 Sep 15;191(6):3319-27. doi: 10.4049/jimmunol.1300940. Epub 2013 Aug 21.


Inhibition of TTR aggregation-induced cell death--a new role for serum amyloid P component.

Andersson K, Pokrzywa M, Dacklin I, Lundgren E.

PLoS One. 2013;8(2):e55766. doi: 10.1371/journal.pone.0055766. Epub 2013 Feb 4.


Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.

Crawford JR, Bjorklund NL, Taglialatela G, Gomer RH.

Neurochem Res. 2012 Apr;37(4):795-801. doi: 10.1007/s11064-011-0674-0. Epub 2011 Dec 29.


Human serum amyloid P functions as a negative regulator of the innate and adaptive immune responses to DNA vaccines.

Wang Y, Guo Y, Wang X, Huang J, Shang J, Sun S.

J Immunol. 2011 Mar 1;186(5):2860-70. doi: 10.4049/jimmunol.1003641. Epub 2011 Jan 28.


Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach.

Chen HM, Lin CY, Wang V.

Clin Biochem. 2011 Apr;44(5-6):377-85. doi: 10.1016/j.clinbiochem.2011.01.002. Epub 2011 Jan 9.


Role of serum amyloid P in skin graft survival and wound healing in burned patients receiving skin grafts.

Zhang YM, Fang YD, Wang YC, Wang SL, Lei ZY, Liu XW, Mao TC, Fan DL.

Clin Chim Acta. 2011 Jan 30;412(3-4):227-9. doi: 10.1016/j.cca.2010.09.036. Epub 2010 Oct 12. Erratum in: Clin Chim Acta. 2011 Mar 18;412(7-8):670.


Accumulation and expression of serum amyloid P component in human atherosclerotic lesions.

Song Z, Cai L, Guo L, Tsukamoto Y, Yutani C, Li XA.

Atherosclerosis. 2010 Jul;211(1):90-5. doi: 10.1016/j.atherosclerosis.2010.01.046. Epub 2010 Feb 6.


Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.

Verwey NA, Schuitemaker A, van der Flier WM, Mulder SD, Mulder C, Hack CE, Scheltens P, Blankenstein MA, Veerhuis R.

Dement Geriatr Cogn Disord. 2008;26(6):522-7. doi: 10.1159/000178756. Epub 2008 Dec 2. Erratum in: Dement Geriatr Cogn Disord. 2009;27(6):584.


Normal circulating serum amyloid P component concentration in systemic sclerosis.

Tennent GA, Dziadzio M, Triantafillidou E, Davies P, Gallimore JR, Denton CP, Pepys MB.

Arthritis Rheum. 2007 Jun;56(6):2013-7.


Human serum amyloid P component binds to peripheral blood monocytes.

Macdonald SL, Kilpatrick DC.

Scand J Immunol. 2006 Jul;64(1):48-52.


Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q.

Veerhuis R, Boshuizen RS, Morbin M, Mazzoleni G, Hoozemans JJ, Langedijk JP, Tagliavini F, Langeveld JP, Eikelenboom P.

Neurobiol Dis. 2005 Jun-Jul;19(1-2):273-82.


Proteomic characterization of novel serum amyloid P component variants from human plasma and urine.

Kiernan UA, Nedelkov D, Tubbs KA, Niederkofler EE, Nelson RW.

Proteomics. 2004 Jun;4(6):1825-9.


Serum amyloid P component binding to Shiga toxin 2 requires both a subunit and B pentamer.

Marcato P, Vander Helm K, Mulvey GL, Armstrong GD.

Infect Immun. 2003 Oct;71(10):6075-8.


Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages.

Bijl M, Horst G, Bijzet J, Bootsma H, Limburg PC, Kallenberg CG.

Arthritis Rheum. 2003 Jan;48(1):248-54.

Supplemental Content

Support Center